1 – 10 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Biliary tract cancer
- Contribution to journal › Article
-
Mark
A Comprehensive Review of the Epidemiology, Pathophysiology, Risk Factors, and Treatment Strategies for Retinoblastoma
- Contribution to journal › Scientific review
-
Mark
Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified Neuroblastoma
- Contribution to journal › Article
-
Mark
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer : Biomarkers associated with outcomes from OPTIMIZE-1
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : Summary of the 2025 Update
- Contribution to journal › Debate/Note/Editorial
- 2024
-
Mark
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
- Contribution to journal › Article
-
Mark
Prior exposure to alkylating agents negatively impacts testicular organoid formation in cells obtained from childhood cancer patients
- Contribution to journal › Article
-
Mark
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
- Contribution to journal › Article
- 2023
-
Mark
Real-world analysis of MET exon 14 mutations in non-small cell lung cancer : a retrospective study from two Swedish hospitals
- Contribution to journal › Article
-
Mark
Biomarkers or biotargets? Using competition to lure cancer cells into evolutionary traps
- Contribution to journal › Article
